XL 888 clinical trials
Also written XL888.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses XL 888 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 3
H. Lee Moffitt Cancer Center and Research Institute (2) · Emory University (1) · Exelixis (1)
Studies
Open first, then newest update. How each study uses XL 888 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerCompletedPhase 1Emory UniversityNCT03095781Written as XL888
- XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV MelanomaActive, not recruitingPhase 1H. Lee Moffitt Cancer Center and Research InstituteNCT02721459Written as XL888
- Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV MelanomaCompletedPhase 1H. Lee Moffitt Cancer Center and Research InstituteNCT01657591Written as XL888
- Safety Study of Pharmacokinetics of XL888 in Adults With Solid TumorsTerminatedPhase 1ExelixisNCT00796484Written as XL888
Codes
What other systems call XL 888 · ClinicalTrials.gg INT005852
- UNII (FDA) 7M346920EVXL-888Confirmed FDA, Wikidata
- Wikidata Q27268551xl-888Confirmed FDA, Wikidata
- DrugBank DB12981One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 7M346920EV | XL-888 | Confirmed FDA, Wikidata |
| Wikidata | Q27268551 | xl-888 | Confirmed FDA, Wikidata |
| DrugBank | DB12981 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.